Cita APA (7a ed.)
Di Sciullo, M. P., Menay, F., Cocozza, F., Gravisaco, M. J., Waldner, C. I., & Mongini, C. (2019). Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma. Elsevier.
Cita Chicago Style (17a ed.)
Di Sciullo, Maria Paula, Florencia Menay, Federico Cocozza, María José Gravisaco, Claudia Inés Waldner, y Claudia Mongini. Systemic Administration of Imiquimod as an Adjuvant Improves Immunogenicity of a Tumor-lysate Vaccine Inducing the Rejection of a Highly Aggressive T-cell Lymphoma. Elsevier, 2019.
Cita MLA (9a ed.)
Di Sciullo, Maria Paula, et al. Systemic Administration of Imiquimod as an Adjuvant Improves Immunogenicity of a Tumor-lysate Vaccine Inducing the Rejection of a Highly Aggressive T-cell Lymphoma. Elsevier, 2019.
Precaución: Estas citas no son 100% exactas.